Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children - Report - MDSpire

Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children

  • By

  • Weronika Gonciarz

  • Lucyna Kozlowska

  • Marta Stelmasiak

  • Magdalena Wozniczka

  • Magdalena Chmiela

  • June 16, 2026

  • 0 min

Share

Clinical Report: Metabolomic Investigation of Systemic Biomarkers in H. pylori Infection

Overview

Expand on the significance of the identified metabolites in relation to existing literature.

Background

Update with recent statistics on H. pylori prevalence and its impact on pediatric health.

Data Highlights

MetaboliteHMDB ID
Carboxyethyl lysineHMDB29447
Gamma-GlutamylleucineHMDB0011171
13-HOTrEHMDB0341541
13-HODEHMDB0004667
LauroylcarnitineHMDB0002250
Vitamin AHMDB0000305
19_norandrosteroneHMDB0002697

Key Findings

  • Seven metabolites were identified that differentiate H. pylori-infected from uninfected children.
  • Metabolites are associated with immune regulation, energy metabolism, and oxidative stress.
  • H. pylori infection can lead to chronic gastritis and other serious gastrointestinal diseases.
  • Effective diagnosis and treatment of H. pylori are crucial to prevent complications in pediatric populations.
  • Further studies are needed to validate these metabolites as biomarkers for H. pylori infection.

Clinical Implications

Detail how metabolomic profiling can be integrated into current diagnostic protocols.

Conclusion

This study highlights the potential of metabolomic profiling in understanding H. pylori infection in children. Further validation of these findings could enhance diagnostic and therapeutic approaches in pediatric gastroenterology.

Related Resources & Content

  1. Author(s)/Org, Source, Year -- Title
  2. conexiant, Treat H. pylori Early to Prevent Cancer
  3. Journal of Gastroenterology, Current Understanding and Future Directions of Helicobacter pylori Research in Japan
  4. Infection, The Role of Helicobacter pylori in the Oral-Gut Microbiome: Clinical Significance
  5. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023)
  6. Global Profile of Drug Resistance Related to Helicobacter pylori Infection in Children: A Systematic Review and Meta‐Analysis - Menbari - 2025 - Health Science Reports
  7. Frontiers | Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children
  8. Updated joint ESPGHAN/NASPGHAN guidelines for management of Helicobacter pylori infection in children and adolescents (2023)
  9. Global Profile of Drug Resistance Related to Helicobacter pylori Infection in Children: A Systematic Review and Meta‐Analysis - Menbari - 2025 - Health Science Reports - Wiley Online Library
  10. Frontiers | Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children

Original Source(s)

Exploratory metabolomic analysis for identifying systemic signatures of Helicobacter pylori infection in children

  • by Weronika Gonciarz, Lucyna Kozlowska, Marta Stelmasiak, Magdalena Wozniczka, Magdalena Chmiela

  • June 16, 2026

Related Content

Gastroenterologically relevant high alert medications prescribed to children with chronic diseases—a consensus-driven single-center pilot study

Liver stiffness measured by transient elastography is associated with hepatic Fibrosis in children with portal vein thrombosis: a retrospective cross-sectional study

A Model for Predicting Recurrence of Acute Pancreatitis in Children Using Serological Markers in the Absence of Pancreaticobiliary Anomalies